PNC Financial Services Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $473K | Buy |
13,128
+463
| +4% | +$16.7K | ﹤0.01% | 1604 |
|
|
2025
Q1 | $394K | Buy |
12,665
+859
| +7% | +$26.7K | ﹤0.01% | 1694 |
|
|
2024
Q4 | $301K | Buy |
11,806
+4,129
| +54% | +$105K | ﹤0.01% | 1901 |
|
|
2024
Q3 | $217K | Sell |
7,677
-223
| -3% | -$6.31K | ﹤0.01% | 2124 |
|
|
2024
Q2 | $208K | Sell |
7,900
-4,425
| -36% | -$117K | ﹤0.01% | 2117 |
|
|
2024
Q1 | $374K | Buy |
12,325
+1,378
| +13% | +$41.9K | ﹤0.01% | 1723 |
|
|
2023
Q4 | $308K | Buy |
10,947
+5,438
| +99% | +$153K | ﹤0.01% | 1835 |
|
|
2023
Q3 | $150K | Buy |
5,509
+536
| +11% | +$14.5K | ﹤0.01% | 2324 |
|
|
2023
Q2 | $153K | Buy |
4,973
+337
| +7% | +$10.4K | ﹤0.01% | 2387 |
|
|
2023
Q1 | $167K | Buy |
4,636
+1,256
| +37% | +$45.3K | ﹤0.01% | 2253 |
|
|
2022
Q4 | $134K | Sell |
3,380
-564
| -14% | -$22.3K | ﹤0.01% | 2390 |
|
|
2022
Q3 | $159K | Buy |
3,944
+558
| +16% | +$22.5K | ﹤0.01% | 2238 |
|
|
2022
Q2 | $142K | Sell |
3,386
-37
| -1% | -$1.55K | ﹤0.01% | 2342 |
|
|
2022
Q1 | $133K | Buy |
3,423
+1,208
| +55% | +$46.9K | ﹤0.01% | 2528 |
|
|
2021
Q4 | $88K | Buy |
2,215
+1,627
| +277% | +$64.6K | ﹤0.01% | 2767 |
|
|
2021
Q3 | $20K | Buy |
588
+86
| +17% | +$2.93K | ﹤0.01% | 3504 |
|
|
2021
Q2 | $20K | Buy |
502
+226
| +82% | +$9K | ﹤0.01% | 3475 |
|
|
2021
Q1 | $12K | Buy |
276
+116
| +73% | +$5.04K | ﹤0.01% | 3596 |
|
|
2020
Q4 | $8K | Buy |
+160
| New | +$8K | ﹤0.01% | 3628 |
|